Mast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis

Inflammatory Bowel Diseases · Published 2026-07-08 · DOI 10.1093/ibd/izag127

Free full text

Authors (10)

Kwestan Safari, Wei Jen Ma, Prabhreet Sekhon, Priya Rai, Susan C Menzies, Tomoaki Hoshino, Anne-Sophie Fratzscher, Andrew Roth, Karen Madsen, Laura M Sly

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Safari, K., Ma, W., Sekhon, P., et al. (2026). Mast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag127

Related articles

• Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study · Inflammatory Bowel Diseases · 2026 · Same journal
• Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments · Inflammatory Bowel Diseases · 2026 · Same journal
• Transmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease · Inflammatory Bowel Diseases · 2026 · Same journal
• Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial · Inflammatory Bowel Diseases · 2026 · Same journal
• Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD · Inflammatory Bowel Diseases · 2026 · Same journal
• Inflammatory bowel disease in the aging population · Inflammatory Bowel Diseases · 2026 · Same journal
• Inflammatory bowel disease and risk of perineal injury in primiparous vaginal births: a retrospective cohort study · Inflammatory Bowel Diseases · 2026 · Same journal
• Interpreting oral dysbiosis during nutritional therapy in pediatric Crohn disease · Inflammatory Bowel Diseases · 2026 · Same journal
• Increased risk of respiratory syncytial virus infection in patients with active inflammatory bowel disease: a matched cohort study · Inflammatory Bowel Diseases · 2026 · Same journal
• Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study · Inflammatory Bowel Diseases · 2026 · Same journal